| Biological Sciences | Lifetime | 144 | US 86 | 99.98 |
| Cancer Research | Lifetime | 12 | US 8 | 99.92 |
| Molecular Biology | Lifetime | 137 | US 102 | 99.94 |
| Immunology | Lifetime | 83 | US 53 | 99.86 |
| Oncology | Lifetime | 668 | US 368 | 98.68 |
| Immunology and Allergy | Lifetime | 778 | US 317 | 82.17 |
| Cancer Research | 2021-2025 | 173 | US 59 | 90.81 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 5 | US 3 | 99.98 |
| Cell death mechanisms and regulation | Lifetime | 4 | US 3 | 99.95 |
| Immune Cell Function and Interaction | Lifetime | 69 | US 47 | 99.89 |
| Autophagy in Disease and Therapy | Lifetime | 24 | US 12 | 99.81 |
| Epigenetics and DNA Methylation | Lifetime | 70 | US 49 | 99.72 |
| T-cell and B-cell Immunology | Lifetime | 59 | US 40 | 99.87 |
| Mitochondrial Function and Pathology | Lifetime | 84 | US 37 | 99.58 |
| Metabolism, Diabetes, and Cancer | Lifetime | 57 | US 29 | 99.69 |
| NF-κB Signaling Pathways | Lifetime | 29 | US 14 | 99.61 |
| Cancer-related Molecular Pathways | Lifetime | 94 | US 61 | 99.52 |
| Immunotherapy and Immune Responses | Lifetime | 182 | US 105 | 99.68 |
| Phagocytosis and Immune Regulation | Lifetime | 28 | US 11 | 99.19 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 75 | US 45 | 99.26 |
| Immune Response and Inflammation | Lifetime | 279 | US 134 | 99.26 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 777 | US 408 | 98.75 |
| RNA modifications and cancer | Lifetime | 892 | US 429 | 98.36 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 614 | US 311 | 98.65 |
| RNA Interference and Gene Delivery | Lifetime | 745 | US 296 | 98.15 |
| Signaling Pathways in Disease | Lifetime | 196 | US 101 | 97.65 |
| Glycosylation and Glycoproteins Research | Lifetime | 877 | US 375 | 97.68 |
| ATP Synthase and ATPases Research | Lifetime | 202 | US 68 | 97.65 |
| Cell Adhesion Molecules Research | Lifetime | 759 | US 370 | 97.82 |
| Histone Deacetylase Inhibitors Research | Lifetime | 312 | US 172 | 96.98 |
| Cancer, Lipids, and Metabolism | Lifetime | 734 | US 348 | 97.42 |
| Ubiquitin and proteasome pathways | Lifetime | 791 | US 392 | 96.86 |
| interferon and immune responses | Lifetime | 607 | US 267 | 96.37 |
| Cancer Mechanisms and Therapy | Lifetime | 561 | US 232 | 94.73 |
| Galectins and Cancer Biology | Lifetime | 923 | US 279 | 93.09 |
| Calcium signaling and nucleotide metabolism | Lifetime | 785 | US 266 | 86.96 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 87 | US 24 | 97.13 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 961 | US 237 | 78.83 |